Status:

RECRUITING

Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"

Lead Sponsor:

Cairo University

Collaborating Sponsors:

Aswan Heart Centre

Conditions:

Acute Myocardial Infarction

Dyslipidemias

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

Rationale: Patients with acute coronary syndromes are at an increased risk for recurrent adverse coronary events, particularly during the early period following their initial presentation. Early (in-...

Detailed Description

Introduction: After a major event of "atherosclerotic cardiovascular disease" ASCVD, like a stroke or "Acute Myocardial infarction" AMI, best practice clinical guidelines strongly recommend prompt in...

Eligibility Criteria

Inclusion

  • Age more than 18 years. Both genders are eligible.
  • Acute myocardial infarction (STEMI or NSTEMI) within 48 hours from the onset of symptoms.
  • Baseline LDL-C above 125 mg/dl for those who were not on consistent lipid lowering therapy; or above 100 mg/dl for those who were compliant (≥ 90 days) on moderate intensity statin therapy.

Exclusion

  • Refusal to participate in the study.
  • Proved intolerance to statins on previous use.
  • Having conditions (or taking medications) that would not allow concomitant safe statins use. \[such as patients receiving Cyclosporine - Gemfibrozil -Pazopanib - Tipranavir - Itraconazole - Ketoconazole\]
  • Those who are already compliant on high intensity statins.
  • Those who are already on statins plus non-statin agent (ezetimibe-PCSK9i-BAS).
  • Known familial dyslipidemia or having TG\>500 mg/dl or LDL-C\>190 mg/dl which are highly suggestive of familial or secondary causes.
  • Pregnant or contemplating pregnancy in the following 12 months. \[relevant for females in the child-bearing period\]

Key Trial Info

Start Date :

March 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04701242

Start Date

March 24 2021

End Date

December 1 2025

Last Update

August 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aswan Heart Centre

Aswān, Egypt, 81511